The ongoing challenge of CNS progression in ALK-positive NSCLC

Prof. Geoffrey Liu, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

Host：Prof. Ming Gao, The First Affiliated Hospital of Zhengzhou University, China
Prof. Liu discussed the ongoing challenge of CNS progression in ALK-positive NSCLC, including how to optimize systemic TKI therapy plus local intervention and how to interpret the long-term value of first-line lorlatinib. He also shared his perspectives on treatment sequencing, patient preferences, and future directions in ALK research.

Видео The ongoing challenge of CNS progression in ALK-positive NSCLC канала MedJ